Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze AVXL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AVXL investment potential.

What is AVXL stock price today?

The current AVXL stock price is $4.10 as of 08 Feb '26. Get real-time AVXL stock price, historical data, and price charts on Financhill.

Is AVXL a good investment?

Evaluate AVXL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Anavex Life Sciences Corp. (AVXL) do?

Anavex Life Sciences Corp. (AVXL) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our AVXL company profile page.

How to buy AVXL stock?

To buy AVXL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AVXL?

View detailed market capitalization data and company valuation metrics for AVXL on our comprehensive analysis page.

What is the P/E ratio of AVXL?

Use our fundamental analysis tools to view AVXL P/E ratio and compare valuation metrics with industry peers.

What are AVXL earnings?

View AVXL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Sell

28

AVXL Quote, Financials, Valuation and Earnings

Last price:

$4.10

Seasonality move :

12.08%

Day range:

$3.82 - $4.26

52-week range:

$2.86 - $13.99

Dividend yield:

0%

P/E ratio:

--

P/S ratio:

--

P/B ratio:

3.86x

Volume:

1.7M

Avg. volume:

1.6M

1-year change:

-52.82%

Market cap:

$366.3M

Revenue:

--

EPS (TTM):

-$0.54

Anavex Life Sciences Corp. SEC Filings

Company	Filed	Form Type	Description
AVXL Anavex Life Sciences Corp.	08/08/2023	10-Q	10-Q filing on 08/08/2023	View Form
AVXL Anavex Life Sciences Corp.	05/09/2023	10-Q	10-Q filing on 05/09/2023	View Form
AVXL Anavex Life Sciences Corp.	02/07/2023	10-Q	10-Q filing on 02/07/2023	View Form
AVXL Anavex Life Sciences Corp.	08/09/2022	10-Q	10-Q filing on 08/09/2022	View Form
AVXL Anavex Life Sciences Corp.	05/10/2022	10-Q	10-Q filing on 05/10/2022	View Form
AVXL Anavex Life Sciences Corp.	02/09/2022	10-Q	10-Q filing on 02/09/2022	View Form
AVXL Anavex Life Sciences Corp.	08/12/2021	10-Q	10-Q filing on 08/12/2021	View Form
AVXL Anavex Life Sciences Corp.	05/13/2021	10-Q	10-Q filing on 05/13/2021	View Form
AVXL Anavex Life Sciences Corp.	02/16/2021	10-Q	10-Q filing on 02/16/2021	View Form
AVXL Anavex Life Sciences Corp.	12/28/2020	10-K	10-K filing on 12/28/2020	View Form
AVXL Anavex Life Sciences Corp.	08/06/2020	10-Q	10-Q filing on 08/06/2020	View Form
AVXL Anavex Life Sciences Corp.	05/07/2020	10-Q	10-Q filing on 05/07/2020	View Form
AVXL Anavex Life Sciences Corp.	02/06/2020	10-Q	10-Q filing on 02/06/2020	View Form
AVXL Anavex Life Sciences Corp.	12/16/2019	10-K	10-K filing on 12/16/2019	View Form
AVXL Anavex Life Sciences Corp.	08/07/2019	10-Q	10-Q filing on 08/07/2019	View Form
AVXL Anavex Life Sciences Corp.	05/09/2019	10-Q	10-Q filing on 05/09/2019	View Form
AVXL Anavex Life Sciences Corp.	02/07/2019	10-Q	10-Q filing on 02/07/2019	View Form
AVXL Anavex Life Sciences Corp.	01/25/2019	10-K	10-K filing on 01/25/2019	View Form
AVXL Anavex Life Sciences Corp.	12/12/2018	10-K	10-K filing on 12/12/2018	View Form
AVXL Anavex Life Sciences Corp.	08/09/2018	10-Q	10-Q filing on 08/09/2018	View Form
AVXL Anavex Life Sciences Corp.	05/10/2018	10-Q	10-Q filing on 05/10/2018	View Form
AVXL Anavex Life Sciences Corp.	02/07/2018	10-Q	10-Q filing on 02/07/2018	View Form
AVXL Anavex Life Sciences Corp.	12/11/2017	10-K	10-K filing on 12/11/2017	View Form
AVXL Anavex Life Sciences Corp.	08/07/2017	10-Q	10-Q filing on 08/07/2017	View Form
AVXL Anavex Life Sciences Corp.	05/10/2017	10-Q	10-Q filing on 05/10/2017	View Form
AVXL Anavex Life Sciences Corp.	02/07/2017	10-Q	10-Q filing on 02/07/2017	View Form
AVXL Anavex Life Sciences Corp.	12/14/2016	10-K	10-K filing on 12/14/2016	View Form
AVXL Anavex Life Sciences Corp.	08/11/2016	10-Q	10-Q filing on 08/11/2016	View Form
AVXL Anavex Life Sciences Corp.	05/11/2016	10-Q	10-Q filing on 05/11/2016	View Form
AVXL Anavex Life Sciences Corp.	02/08/2016	10-Q	10-Q filing on 02/08/2016	View Form

Related Companies

Get AVXL Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

AVXL

Sector

P/E ratio

--

23.40x

PEG ratio

-1.31x

-0.01x

P/B ratio

3.86x

1.74x

Price / LTM sales

--

1.48x

Growth Metrics

AVXL

Sector

Revenue growth

--

3.36%

Earnings growth

16.5%

9.35%

Revenue (5-year growth)

--

6.22%

Earnings forecast

-$0.11

-$0.19

Profitability

AVXL

Sector

Profitability FY 2025

--

$2.7M

Return on invested capital

-44.87%

-33.62%

Return on assets

-39.77%

-29.68%

Return on equity

-44.87%

-38.98%

Earnings Date

Last Earnings Date

Nov

25

Next Earnings Date

Feb

9

Estimated Next Earnings Date

Feb

24

Balance Sheet

AVXL

Sector

Total cash

$102.6M

$25M

Short term investments

--

$23.9M

Total assets

$103.8M

$72.5M

Long term debt

--

$2.6M

Stock Ideas

Buy

56

Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy or Sell?

Buy

61

Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy or Sell?

Buy

53

Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Buy or Sell?

Alerts

Sell

40

BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy or Sell?

Buy

75

PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Buy or Sell?

Sell

30

MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Anavex Life Sciences Corp. SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get AVXL Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?

Is Lumentum The Best Laser Stock to Buy?

Is Planet Fitness Stock Undervalued?

Stock Ideas

Is NVDA Stock a Buy?

Is AAPL Stock a Buy?

Is GOOG Stock a Buy?

Alerts

BILL alert for Feb 7

PRLB alert for Feb 7

MSTR alert for Feb 7

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS